Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 95
Filtrar
1.
Arch. argent. pediatr ; 122(4): e202310137, ago. 2024. ilus
Artículo en Inglés, Español | LILACS, BINACIS | ID: biblio-1562880

RESUMEN

La púrpura fulminante adquirida postinfecciosa es una entidad aguda y grave, poco frecuente, caracterizada por necrosis cutánea asociada a coagulopatía intravascular diseminada (CID), en ausencia de infección activa o alteraciones previas de la coagulación. Afecta fundamentalmente a la población pediátrica y, en el 90 % de los casos, está precedida por un proceso infeccioso. El mecanismo fisiopatológico es un déficit transitorio de proteína S mediado por autoanticuerpos que favorece un estado de hipercoagulabilidad. Se presenta el caso de un varón de 8 años previamente sano, con lesiones cutáneas purpúricas características de púrpura fulminante asociada a CID en ausencia de sepsis. Se constató deficiencia plasmática transitoria de proteína S. Requirió tratamiento sustitutivo con plasma fresco congelado y anticoagulación; la evolución fue favorable. La actividad de la proteína S permaneció disminuida durante 2 meses.


Acquired postinfectious purpura fulminans is a rare, acute, and severe disease characterized by skin necrosis associated with disseminated intravascular coagulation (DIC) in the absence of active infection or previous coagulation disorders. It mainly affects the pediatric population and, in 90% of cases, it is preceded by an infectious process. The pathophysiological mechanism is a transient autoantibodymediated protein S deficiency that favors a hypercoagulable state. Here we describe the case of a previously healthy 8-year-old boy with purpuric skin lesions typical of purpura fulminans associated with DIC in the absence of sepsis. A transient plasma protein S deficiency was confirmed. He required replacement therapy with fresh frozen plasma and anticoagulation; he had a favorable course. Protein S activity remained decreased for 2 months.


Asunto(s)
Humanos , Masculino , Niño , Púrpura Fulminante/diagnóstico , Púrpura Fulminante/etiología , Deficiencia de Proteína S/complicaciones , Deficiencia de Proteína S/diagnóstico , Coagulación Intravascular Diseminada/diagnóstico , Coagulación Intravascular Diseminada/etiología
3.
BMJ Case Rep ; 17(3)2024 Mar 25.
Artículo en Inglés | MEDLINE | ID: mdl-38531552

RESUMEN

Purpura fulminans (PF) is a life-threatening complication of septic shock that can occur due to disseminated infections with Streptococcus pneumoniae The spleen is an important organ in the immunisation process against encapsulated bacteria. Patients with asplenia, either functional or anatomical, are therefore at increased risk of developing serious infections and complications, such as PF, if infected with such bacteria.This case report presents a woman in her late 40s with unacknowledged functional asplenia who was admitted to the hospital with signs of an acute disseminated infection causing septic shock, signs of disseminated intravascular coagulation and infectious PF. A few days after admission, the blood cultures showed growth of S. pneumoniae With early sepsis treatment, the patient survived although with some complications. Clinical presentation, investigations, differential diagnosis, treatment and outcome are presented. Treatment and early recognition of PF are presented and discussed. Relevant recognition and preventative treatment strategies for patients with asplenia are also reviewed and discussed.This case demonstrates the importance of early recognition and treatment of PF in septic patients and the importance of preventive treatment strategies for patients with asplenia to avoid serious infections and complications.


Asunto(s)
Bacteriemia , Infecciones Neumocócicas , Púrpura Fulminante , Sepsis , Choque Séptico , Enfermedades del Bazo , Femenino , Humanos , Púrpura Fulminante/diagnóstico , Choque Séptico/complicaciones , Infecciones Neumocócicas/microbiología , Streptococcus pneumoniae , Sepsis/complicaciones , Bacteriemia/complicaciones , Enfermedades del Bazo/complicaciones
4.
Arch Argent Pediatr ; 122(4): e202310137, 2024 08 01.
Artículo en Inglés, Español | MEDLINE | ID: mdl-38231644

RESUMEN

Acquired postinfectious purpura fulminans is a rare, acute, and severe disease characterized by skin necrosis associated with disseminated intravascular coagulation (DIC) in the absence of active infection or previous coagulation disorders. It mainly affects the pediatric population and, in 90% of cases, it is preceded by an infectious process. The pathophysiological mechanism is a transient autoantibody-mediated protein S deficiency that favors a hypercoagulable state. Here we describe the case of a previously healthy 8-year-old boy with purpuric skin lesions typical of purpura fulminans associated with DIC in the absence of sepsis. A transient plasma protein S deficiency was confirmed. He required replacement therapy with fresh frozen plasma and anticoagulation; he had a favorable course. Protein S activity remained decreased for 2 months.


La púrpura fulminante adquirida postinfecciosa es una entidad aguda y grave, poco frecuente, caracterizada por necrosis cutánea asociada a coagulopatía intravascular diseminada (CID), en ausencia de infección activa o alteraciones previas de la coagulación. Afecta fundamentalmente a la población pediátrica y, en el 90 % de los casos, está precedida por un proceso infeccioso. El mecanismo fisiopatológico es un déficit transitorio de proteína S mediado por autoanticuerpos que favorece un estado de hipercoagulabilidad. Se presenta el caso de un varón de 8 años previamente sano, con lesiones cutáneas purpúricas características de púrpura fulminante asociada a CID en ausencia de sepsis. Se constató deficiencia plasmática transitoria de proteína S. Requirió tratamiento sustitutivo con plasma fresco congelado y anticoagulación; la evolución fue favorable. La actividad de la proteína S permaneció disminuida durante 2 meses.


Asunto(s)
Púrpura Fulminante , Humanos , Púrpura Fulminante/etiología , Púrpura Fulminante/diagnóstico , Masculino , Niño , Deficiencia de Proteína S/complicaciones , Deficiencia de Proteína S/diagnóstico , Coagulación Intravascular Diseminada/etiología , Coagulación Intravascular Diseminada/diagnóstico
5.
Med Klin Intensivmed Notfmed ; 118(8): 646-655, 2023 Nov.
Artículo en Alemán | MEDLINE | ID: mdl-37466696

RESUMEN

Febrile seizures, which are relatively common in young children, are often triggered by an infection and resolve quickly. Prompt presentation to a pediatric department is mandatory after any first seizure and every time for children ≤ 12 months. Central nervous system (CNS) diseases in childhood are able to cause seizures or other neurological disorders. Even the slightest suspicion of a seizure with CNS involvement must be promptly treated. In case of doubt, both an antiviral and an antibacterial treatment are started in parallel, which can be stopped after detecting the pathogen. Lumbar puncture is strictly indicated unless there are contraindications. Meningococcal sepsis is a severe clinical feature comprising high fever, chills and disorders of consciousness. The first skin symptoms are petechiae as a red flag sign. With progression, potentially lethal purpura fulminans may develop. Waterhouse-Friderichsen syndrome is a severe complication of acute bacterial meningitis. Lethality rate is 35%. The pediatric assessment triangle and the ABCDE algorithm help to identify critically ill children in a standardized, structured, and rapid manner.


Asunto(s)
Meningitis Bacterianas , Púrpura Fulminante , Convulsiones Febriles , Niño , Humanos , Lactante , Preescolar , Convulsiones Febriles/diagnóstico , Convulsiones Febriles/etiología , Convulsiones Febriles/terapia , Púrpura Fulminante/diagnóstico , Púrpura Fulminante/terapia , Púrpura Fulminante/complicaciones , Urgencias Médicas , Meningitis Bacterianas/complicaciones , Meningitis Bacterianas/diagnóstico , Meningitis Bacterianas/terapia , Punción Espinal/efectos adversos
6.
Clin Lab ; 69(5)2023 May 01.
Artículo en Inglés | MEDLINE | ID: mdl-37145086

RESUMEN

BACKGROUND: Congenital protein C deficiency is a rare hereditary thrombophilia, neonatal purpura fulminans is the most serious form of this deficit. The purpose of this observation is two-fold. The first is the need to make an early diagnosis in order to improve the prognosis. The second, is to discuss the need. In case of extensive purpura fulminans in the neonatal period, the search for a deficiency in anticoagulant factor, in particular the dosage of protein C, in the newborn and in both parents. METHODS: The diagnosis is biological and is based on the quantitative determination of functionally active protein C. We use the Berichrom® Protein C assay on an automated coagulation analyzer from Siemens Healthcare Diagnostics, which allows the chromogenic determination of Protein C activity. RESULTS: We report an observation of cutaneous necrosis in a newborn having developed a purpura fulminans extensive secondary to a total congenital protein C deficiency. In front of this clinical picture, thrombophilia assessment is requested, revealing an isolated deficit in protein C < 1%. CONCLUSIONS: In the case of extensive purpura fulminans in the neonatal period, the search for a deficiency in anticoagulant factor, in particular the dosage of protein C, is essential in the newborn and in both parents.


Asunto(s)
Deficiencia de Proteína C , Púrpura Fulminante , Trombofilia , Recién Nacido , Humanos , Púrpura Fulminante/diagnóstico , Púrpura Fulminante/complicaciones , Deficiencia de Proteína C/complicaciones , Deficiencia de Proteína C/diagnóstico , Proteína C , Trombofilia/complicaciones , Anticoagulantes
8.
Rev Prat ; 73(1): 71-78, 2023 Jan.
Artículo en Francés | MEDLINE | ID: mdl-36820463

RESUMEN

PURPURA FULMINANS IN ADULT PATIENTS. Purpura fulminans is a rare life-threatening infectious disease characterized by the association of a sudden and extensive purpuric rash together with an acute circulatory failure. PF commonly affects young patients with no previous comorbidities. Neisseria meningitidis and Streptococcus pneumoniae are the leading causative bacteria. Diagnosing purpura fulminans before the apparition of the purpuric rash is challenging since prodromal symptoms are nonspecific and consistent with a "flu-like" syndrome. The clinical presentation of patients with purpura fulminans differs from that of patients with bacterial meningitis since most of the patients with purpura fulminans have no neurological impairment. Microbiological diagnosis relies on blood cultures and skin biopsy of purpuric lesions. The indication for lumbar puncture must be evaluated on a case-by-case basis because patients usually have no neurological signs but severe coagulation disorders. Treatment is no different from that of any other septic shock: antibiotic therapy with a third-generation cephalosporin as soon as the diagnosis is suspected and treatment of associated organ failures. Despite these pathogens being highly susceptible to broadly available antibiotics, the prognosis of PF is dismal with a mortality rate of 40% in the intensive care unit and a significant risk of distant sequelae in surviving patients.


PURPURA FULMINANS DE L'ADULTE. Le purpura fulminans (PF) est une maladie infectieuse rare touchant préférentiellement l'adulte jeune sans comorbidités. Il se définit par l'association d'un état de choc septique et d'un purpura d'apparition et d'extension rapides. Les deux principales bactéries responsables sont le méningocoque et le pneumocoque. L'éruption purpurique est précédée par une phase prodromique faite de symptômes aspécifiques (syndrome pseudogrippal) rendant difficile un diagnostic précoce. La présentation clinique des patients ayant un purpura fulminans diffère de celle des patients ayant une méningite bactérienne. Le diagnostic microbiologique repose sur les hémocultures et sur la biopsie cutanée. L'indication de la ponction lombaire est à évaluer au cas par cas car les patients n'ont le plus souvent aucun signe neurologique mais des troubles sévères de l'hémostase contre-indiquant le geste. La prise en charge des patients ayant un PF n'a aucune spécificité comparativement à celle des patients ayant un choc septique lié à une autre porte d'entrée : antibiothérapie par une céphalosporine de troisième génération dès la suspicion diagnostique et traitement des défaillances d'organes associées. Bien que les bactéries responsables de purpura fulminans soient extrêmement sensibles aux antibiotiques, le pronostic du PF reste sombre, avec une mortalité en réanimation s'élevant à 40 % et un risque important de séquelles à distance chez les patients survivants.


Asunto(s)
Exantema , Neisseria meningitidis , Púrpura Fulminante , Humanos , Adulto , Púrpura Fulminante/diagnóstico , Púrpura Fulminante/microbiología , Púrpura Fulminante/patología , Piel/patología , Antibacterianos/uso terapéutico
9.
J Burn Care Res ; 44(2): 485-486, 2023 03 02.
Artículo en Inglés | MEDLINE | ID: mdl-36402743

RESUMEN

Purpura fulminans (PF) is a life-threatening emergency involving coagulopathy and widespread skin necrosis. Early treatment, especially surgical management, is imperative as prognosis can be very poor. PF is most commonly associated with severe bacterial illness; however, viral causes are also possible. Currently in the literature, there have only been a handful of PF cases associated with COVID-19. We present two cases of PF in the setting of COVID-19 infection. Both patients had a history of underlying coagulopathies. PF can be a sign of underlying coagulopathy in a COVID-19 patient, who is already at increased risk for thromboembolic events due to the inflammatory nature of COVID itself. Due to how quickly PF can develop into life-threatening necrosis and multiorgan failure, it is imperative that these patients are referred early to a burn center for more advanced care.


Asunto(s)
Quemaduras , COVID-19 , Púrpura Fulminante , Humanos , Púrpura Fulminante/etiología , Púrpura Fulminante/terapia , Púrpura Fulminante/diagnóstico , COVID-19/complicaciones , Quemaduras/complicaciones , Pronóstico , Necrosis
11.
Blood Adv ; 6(2): 495-502, 2022 01 25.
Artículo en Inglés | MEDLINE | ID: mdl-34788405

RESUMEN

Idiopathic purpura fulminans (IPF) is a rare but severe prothrombotic coagulation disorder that can occur after chickenpox or human herpesvirus 6 (HHV-6) infection. IPF leads to an autoantibody-mediated decrease in the plasma concentration of protein S. We conducted a retrospective multicenter study involving patients with IPF from 13 French pediatric centers and a systematic review of cases in published literature. Eighteen patients were included in our case series, and 34 patients were included as literature review cases. The median age was 4.9 years, and the diagnostic delay after the first signs of viral infection was 7 days. The lower limbs were involved in 49 patients (94%) with typical lesions. In all, 41 patients (78%) had a recent history of varicella-zoster virus infection, and 7 patients (14%) had been infected by HHV-6. Most of the patients received heparin (n = 51; 98%) and fresh frozen plasma transfusions (n = 41; 79%); other treatment options were immunoglobulin infusion, platelet transfusion, corticosteroid therapy, plasmapheresis, and coagulation regulator concentrate infusion. The antithrombin level and platelet count at diagnosis seemed to be associated with severe complications. Given the rarity of this disease, the creation of a prospective international registry is required to consolidate these findings.


Asunto(s)
Varicela , Púrpura Fulminante , Varicela/complicaciones , Niño , Preescolar , Diagnóstico Tardío/efectos adversos , Humanos , Estudios Multicéntricos como Asunto , Estudios Prospectivos , Proteína S , Púrpura Fulminante/diagnóstico , Púrpura Fulminante/etiología , Púrpura Fulminante/terapia , Estudios Retrospectivos
12.
Arch Pediatr ; 28(6): 488-490, 2021 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-34246502

RESUMEN

We report the case of a 7-year-old girl with septic shock and coagulopathy associated with purpura fulminans (PF) and diffuse alveolar hemorrhage (DAH) due to group A Streptococcus (GAS) infection identified with 16S ribosomal RNA analysis performed on the skin biopsy. GAS infection with PF associated with DAH is rare in healthy young children but pediatricians should be aware of this condition because of the poor prognosis. The initial treatment for circulatory failure and severe disseminated intravascular coagulation as well as the prompt initiation of antibiotic treatment may be crucial for the outcomes of S. pyogenes PF.


Asunto(s)
Hemorragia/etiología , Alveolos Pulmonares/anomalías , Púrpura Fulminante/complicaciones , Infecciones Estreptocócicas/complicaciones , Antibacterianos/uso terapéutico , Niño , Femenino , Hemorragia/fisiopatología , Humanos , Alveolos Pulmonares/fisiopatología , Púrpura Fulminante/diagnóstico , Infecciones Estreptocócicas/diagnóstico
14.
BMJ Case Rep ; 14(1)2021 Jan 26.
Artículo en Inglés | MEDLINE | ID: mdl-33500295

RESUMEN

A 42-year-old woman with a history of acute myeloid leukaemia status postallogeneic stem cell transplant presented with fevers, altered mental status, pulmonary infiltrates and septic shock that further progressed to thrombocytopenia and purpura fulminans. Laboratory studies were consistent with a diagnosis of thrombotic thrombocytopenic purpura (TTP). Blood cultures grew Streptococcus pneumoniae On chart review, our patient had a history of low immunoglobulin levels following stem cell transplant, which may have predisposed her to pneumococcal infection. The patient responded to therapy with ceftriaxone, plasma exchange, rituximab and caplacizumab. This is the fourth-documented case of pneumococcal induced TTP and, to the best of our knowledge, the first-describing pneumococcal induced TTP with purpura fulminans. We conclude that patients with TTP should be evaluated for infectious aetiologies and empiric antibiotics should be considered. Clinicians should be aware of the possibility for TTP to lead to purpura fulminans.


Asunto(s)
Bacteriemia/complicaciones , Infecciones Neumocócicas/complicaciones , Púrpura Trombocitopénica Trombótica/etiología , Choque Séptico/complicaciones , Adulto , Antibacterianos/uso terapéutico , Bacteriemia/sangre , Bacteriemia/terapia , Ceftriaxona/uso terapéutico , Diagnóstico Diferencial , Femenino , Fibrinolíticos/uso terapéutico , Dedos/patología , Dedos/cirugía , Gangrena , Glucocorticoides/uso terapéutico , Enfermedad Injerto contra Huésped/tratamiento farmacológico , Humanos , Factores Inmunológicos/uso terapéutico , Leucemia Mieloide Aguda/terapia , Nariz/patología , Intercambio Plasmático , Infecciones Neumocócicas/sangre , Infecciones Neumocócicas/terapia , Púrpura Fulminante/sangre , Púrpura Fulminante/diagnóstico , Púrpura Trombocitopénica Trombótica/sangre , Púrpura Trombocitopénica Trombótica/terapia , Rituximab/uso terapéutico , Choque Séptico/sangre , Choque Séptico/terapia , Anticuerpos de Dominio Único/uso terapéutico , Trasplante de Células Madre , Dedos del Pie/patología , Dedos del Pie/cirugía
17.
Korean J Anesthesiol ; 74(3): 266-270, 2021 06.
Artículo en Inglés | MEDLINE | ID: mdl-32689761

RESUMEN

BACKGROUND: Pregnancy-related infections are the third most common cause of maternal death worldwide. The aim of this report is to present a case of pregnancy-related infection, which progressed into refractory septic shock accompanied by purpura fulminans and multiple organ failure. CASE: A 23-year-old woman in the postpartum period developed fulminant, refractory septic shock complicated by purpura fulminans and multiple organ failure syndrome (acute respiratory distress syndrome, acute kidney injury, and encephalopathy). Management included antibacterial therapy, fluid and transfusion therapy, nutritional support, protective mechanical ventilation, hydrocortisone, a large dose of ascorbic acid, and thiamine. There were no neurological consequences and all organ functions returned to normal, although the predicted hospital mortality based on the Sequential Organ Failure Assessment (SOFA) score was more than 90%. CONCLUSIONS: Septic shock is a significant, yet not completely understood life-threatening condition, which can be associated with purpura fulminans, multiple organ dysfunction, disseminated intravascular coagulation, and massive tissue necrosis.


Asunto(s)
Púrpura Fulminante , Choque Séptico , Adulto , Antibacterianos/uso terapéutico , Femenino , Humanos , Insuficiencia Multiorgánica/tratamiento farmacológico , Insuficiencia Multiorgánica/terapia , Embarazo , Púrpura Fulminante/diagnóstico , Púrpura Fulminante/etiología , Púrpura Fulminante/terapia , Respiración Artificial , Choque Séptico/diagnóstico , Choque Séptico/etiología , Choque Séptico/terapia , Adulto Joven
19.
Trop Doct ; 50(4): 330-334, 2020 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-32998655

RESUMEN

Acute infectious purpura fulminans is a serious, potentially fatal condition. We present a case series of 11 patients from March 2005 to March 2017, whose clinical symptoms were fever (100%), confusion (63.6%) and headache (55%), and whose common laboratory abnormalities were thrombocytopenia (100%), elevated alkaline phosphatase (70%) and anaemia (63.6%). Three patients (27%) developed gangrene and two presented in shock. Only one grew Neisseria meningitidis in cerebrospinal fluid (CSF) culture and another confirmed by latex agglutination and polymerase chain reaction in CSF. Five others had serology confirmed spotted fever rickettsioses (SFG). All received broad spectrum antibiotics; in 9/11 patients, this included doxycycline or azithromycin. The mean hospital stay was 10.2 days and overall mortality was 18.2%.


Asunto(s)
Púrpura Fulminante/diagnóstico , Púrpura Fulminante/terapia , Adulto , Antibacterianos/uso terapéutico , Bacterias/efectos de los fármacos , Bacterias/aislamiento & purificación , Femenino , Hospitalización , Humanos , India , Masculino , Persona de Mediana Edad , Púrpura Fulminante/mortalidad , Púrpura Fulminante/patología , Rickettsiosis Exantemáticas/diagnóstico , Rickettsiosis Exantemáticas/tratamiento farmacológico , Rickettsiosis Exantemáticas/mortalidad , Rickettsiosis Exantemáticas/patología , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA